EMCDDA Home
  • EN
Search

Table TDI-103. All clients entering outpatient treatment by primary drug and age, 2011 or most recent year available

Part (viii) All 'other drugs' outpatient clients by country and by age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium04162021731788088
Bulgaria02718332824251370137
Czech Republic03201201909
Denmark0615128971471071
Germany88121422116610570909551956
Estonia:::::::::::
Ireland17812620123351570157
Greece00202010505
Spain1034381171854054
France1645344958543184371::
Italy2001723561549872478255
Cyprus00100000101
Latvia341957785560060
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary082117783468068
Malta:1::21:::::
Netherlands1111420222013441450145
Austria0943110018018
Poland4424713:::::
Portugal506820274119531740174
Romania2775831194101923195
Slovenia::1::::::::
Slovakia00000000000
Finland0121510010010
Sweden12141699521471071
United Kingdom639125878611468701016900690
Croatia1112440316::
Turkey:::::::::::
Norway7050247241184129133202118601186
Total845498068107675274417674725124350
 

Notes:

: Indicates no data available.

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

(7) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-10 part(iii), part(iv)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013